<SEC-DOCUMENT>0001171843-20-004451.txt : 20200619
<SEC-HEADER>0001171843-20-004451.hdr.sgml : 20200619
<ACCEPTANCE-DATETIME>20200619132048
ACCESSION NUMBER:		0001171843-20-004451
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20200619
FILED AS OF DATE:		20200619
DATE AS OF CHANGE:		20200619

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Genfit S.A.
		CENTRAL INDEX KEY:			0001757064
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			I0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38844
		FILM NUMBER:		20975137

	BUSINESS ADDRESS:	
		STREET 1:		PARC EURASANTE
		STREET 2:		885, AVENUE EUGENE AVINEE
		CITY:			LOOS
		STATE:			I0
		ZIP:			59120
		BUSINESS PHONE:		33 3 20 16 4000

	MAIL ADDRESS:	
		STREET 1:		PARC EURASANTE
		STREET 2:		885, AVENUE EUGENE AVINEE
		CITY:			LOOS
		STATE:			I0
		ZIP:			59120
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>f6k_061920.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES </B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 6-K </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REPORT OF FOREIGN PRIVATE ISSUER </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO RULE 13a-16 OR 15d-16 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNDER THE SECURITIES EXCHANGE ACT OF
1934 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Date of report: June 19, 2020 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Commission File Number: 001-38844 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>GENFIT S.A. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Translation of registrant&rsquo;s name
into English) </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Parc Eurasant&eacute;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>885, avenue Eug&egrave;ne Avin&eacute;e</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>59120 Loos, France</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Address of principal executive office)
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant files or will
file annual reports under cover of Form 20-F or Form 40-F:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 20%; text-align: left">&#9746; Form 20-F</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 79%; text-align: left">&#9744; Form 40-F</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(1): &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(7): &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; padding-top: 12pt; padding-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 11pt"><B>Explanatory
Note</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>General Meeting </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Genfit S.A. (the &ldquo;Company&rdquo;)
has reconvened its Ordinary Shareholders&rsquo; Meeting (the &ldquo;Meeting&rdquo;) on June 30, 2020 beginning at 3:00 pm. CEST
at the Company&rsquo;s headquarters located Parc Eurasant&eacute;, 885 avenue Eug&egrave;ne Avin&eacute;e in Loos (59120), France
as a result of not reaching the required quorum at the Ordinary Shareholders&rsquo; Meeting called on June 11, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Due to ongoing lockdown and prohibition
on public gatherings currently imposed by the French government to prevent the spread of Coronavirus (Covid-19), upon decision
of the Board of Directors of the Company, the Shareholders&rsquo; Meeting will be held exceptionally behind closed doors, that
is to say without the physical presence of shareholders and others who are usually entitled to attend, in accordance with the provisions
of Article 4 of Ordinance No. 2020-321 of March 25, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following documents regarding the Company&rsquo;s
Meeting, which are attached as exhibits hereto, are incorporated by reference herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>



<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; padding-top: 12pt; padding-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT LIST</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; width: 6%">  <B>Exhibit</B></TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center; width: 90%">  <B>Description</B></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><A HREF="exh_991.htm"> 99.1</A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="exh_991.htm"> Press Release dated June 19, 2020.</A></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><A HREF="exh_992.htm">99.2</A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="exh_992.htm">Notice of Shareholders&rsquo; Meeting of Genfit S.A., including Agenda</A></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; padding-top: 12pt; padding-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
    <TD STYLE="width: 48%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="width: 43%">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GENFIT S.A.</B></FONT></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: June 19, 2020</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Pascal PRIGENT</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Pascal PRIGENT</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exh_991.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; color: #005478"><IMG SRC="logo.jpg" ALT=""><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-bottom: 0pt; color: #005478"><B>&nbsp;</B></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-bottom: 0pt; color: #005478"><FONT STYLE="font-size: 14pt"><B>GENFIT:
Annual Shareholders Meeting on second convening to be</B></FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-bottom: 0pt; color: #005478"><FONT STYLE="font-size: 14pt"><B>held on June 30, 2020 at 3:00 pm CEST</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 5.55pt; text-align: justify; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #005278"><B>Lille
(France); Cambridge (Massachusetts, United States) &mdash; June 19, 2020 &mdash; </B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif">GENFIT
(Nasdaq and Euronext: GNFT)</FONT></B>, a late-stage biopharmaceutical company dedicated to improving the lives of patients with
metabolic and chronic liver diseases, today announced that it published in the June 19, 2020 French legal announcements bulletin
(<FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Bulletin des Annonces L&eacute;gales Obligatoires</I></FONT>), its
convening notice for the Annual Shareholders Meeting to be held on Tuesday, June 30, 2020, at 3:00 pm CEST.</P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 5.6pt; text-align: justify; margin-bottom: 0pt">In accordance with the provisions
of Article 4 of Ordinance No. 2020-321 of March 25, 2020, the Shareholders Meeting on second convening will be held virtually from
the Company&rsquo;s headquarters located Parc Eurasant&eacute;, 885 avenue Eug&egrave;ne Avin&eacute;e Loos, 59120, France, with
the same agenda as the June 11, 2020 Shareholders Meeting that could not validly meet as a result of its failure to obtain the
required quorum. The resolutions that will be submitted to the June 30, 2020 Shareholders Meeting remain unchanged.</P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 5.7pt; text-align: justify; margin-bottom: 0pt">The second part
of the second Shareholders Meeting convening notice published in the June 19, 2020 French legal announcements bulletin (<FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Bulletin
des Annonces L&eacute;gales Obligatoires</I></FONT>) and available in the Investors &amp; Media section of the Company&rsquo;s
website (https://ir.genfit.com/financial-information/shareholders-meeting) outlines the procedures by which shareholders may participate
in the Meeting notwithstanding the exceptional measures required in order to comply with regulatory constraints and ensure the
health and safety of our shareholders.</P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 5.75pt; text-align: justify; margin-bottom: 0pt">Shareholders
who have not previously done so can provide their voting instructions via the Internet through the VOTACCESS platform which has
been reopened as of today. The Shareholders Meeting will be available via live audio broadcast and a recording will be made available
through the <FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Investors</I></FONT> section of our website (https://ir.genfit.com)
under the <FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Events </I></FONT>section and on the <FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Shareholders
Meeting</I></FONT> page under <FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Financials.</I></FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 0pt"><I>&nbsp;</I></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 5.8pt; text-align: justify; margin-bottom: 0pt">In accordance with articles
R.225-77 and R.225-79 of the French Commercial Code, proxy forms sent to the Company, electronic votes and voting powers given
to the shareholders meeting on first convening remain valid for the Shareholders Meeting on second convening to be held on June
30, 2020, as long as the shares voted remain in the respective shareholders&rsquo; accounts.</P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; padding-top: 12pt; padding-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 90%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #706F61"><B>GENFIT</B></FONT> <FONT STYLE="color: #706F61">| 885 Avenue Eug&egrave;ne Avin&eacute;e, 59120 Loos - FRANCE | +333 2016 4000 |</FONT> <FONT STYLE="color: #706F61">www.genfit.com</FONT></P></TD><TD STYLE="width: 10%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo --><FONT STYLE="color: #706F61">1</FONT><!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt">&nbsp;<IMG SRC="logo.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 0pt; text-align: justify; color: #005478">&nbsp;</P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 0pt; text-align: justify; color: #005478"><B>ABOUT GENFIT</B></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 5.6pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 5.6pt; margin-bottom: 0pt; text-align: justify">GENFIT is a
late-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutic and diagnostic solutions
in metabolic and liver related diseases where there are considerable unmet medical needs, corresponding to a lack of approved
treatments. GENFIT is a leader in the field of nuclear receptor-based drug discovery, with a rich history and strong scientific
heritage spanning almost two decades. Its most advanced drug candidate, elafibranor, is currently being evaluated in a pivotal
Phase 3 clinical trial (&ldquo;RESOLVE-IT&rdquo;) as a potential treatment for NASH, and GENFIT plans to initiate a Phase 3 clinical
trial of elafibranor in PBC. As part of GENFIT&rsquo;s comprehensive approach to clinical management of patients with NASH, GENFIT
is also developing a new, non-invasive blood-based diagnostic test, NIS4, which, if approved, could enable easier identification
of patients with NASH. With facilities in Lille and Paris, France, and Cambridge, MA, USA, the Company has approximately 200 employees.
GENFIT is a publicly traded company listed on the Nasdaq Global Select Market and in compartment B of Euronext&rsquo;s regulated
market in Paris (Nasdaq and Euronext: GNFT). www.genfit.com</P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 0pt; text-align: justify; color: #005478"><B>FORWARD LOOKING
STATEMENTS</B></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 5.7pt; margin-bottom: 0pt; text-align: justify">This press release contains
certain forward-looking statements, including those within the meaning of the Private Securities Litigation Reform Act of 1995,
with respect to GENFIT, including statements regarding the reconvening of our shareholders meeting. The use of certain words, including
&ldquo;believe,&rdquo; &ldquo;potential,&rdquo; &ldquo;expect&rdquo; and &ldquo;will&rdquo; and similar expressions, is intended
to identify forward-looking statements. Although the Company believes its expectations are based on the current expectations and
reasonable assumptions of the Company&rsquo;s management, these forward-looking statements are subject to numerous known and unknown
risks and uncertainties, which could cause actual results to differ materially from those expressed in, or implied or projected
by, the forward-looking statements. These risks and uncertainties include, among other things, the uncertainties inherent in research
and development, including related to safety, biomarkers, progression of, and results from, its ongoing and planned clinical trials,
review and approvals by regulatory authorities of its drug and diagnostic candidates and the Company&rsquo;s continued ability
to raise capital to fund its development, as well as those risks and uncertainties discussed or identified in the Company&rsquo;s
public filings with the French Autorit&eacute; des march&eacute;s financiers (&ldquo;AMF&rdquo;), including those listed in Section
2.1 &ldquo;Main Risks and Uncertainties&rdquo; of the Company&rsquo;s 2019 Universal Registration Document filed with the AMF on
May 27, 2020 under n&deg; D.20-0503, which is available on GENFIT&rsquo;s website (www.genfit.com) and on the website of the AMF
(www.amf-france.org) and public filings and reports filed with the U.S. Securities and Exchange Commission (&ldquo;SEC&rdquo;),
including the Company&rsquo;s 20-F dated May 27, 2020. In addition,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; padding-top: 12pt; padding-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 90%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #706F61"><B>GENFIT</B></FONT> <FONT STYLE="color: #706F61">| 885 Avenue Eug&egrave;ne Avin&eacute;e, 59120 Loos - FRANCE | +333 2016 4000 |</FONT> <FONT STYLE="color: #706F61">www.genfit.com</FONT></P></TD><TD STYLE="width: 10%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo --><FONT STYLE="color: #706F61">2</FONT><!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; text-align: center"><IMG SRC="logo.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 5.75pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 5.75pt; margin-bottom: 0pt; text-align: justify">even if the Company&rsquo;s
results, performance, financial condition and liquidity, and the development of the industry in which it operates are consistent
with such forward-looking statements, they may not be predictive of results or developments in future periods. These forward-looking
statements speak only as of the date of publication of this document. Other than as required by applicable law, the Company does
not undertake any obligation to update or revise any forward-looking information or statements, whether as a result of new information,
future events or otherwise.</P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 0pt; color: #005478"><B>CONTACT</B></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>GENFIT
</B></FONT>| Investors</P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 0pt; text-align: justify">Naomi EICHENBAUM
&ndash; Investor Relations | Tel: +1 (617) 714 5252 | investors@genfit.com</P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>PRESS
RELATIONS </B></FONT>| Media</P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 0pt">H&eacute;l&egrave;ne LAVIN &ndash; Press
relations | Tel: +333 2016 4000 | helene.lavin@genfit.com</P>



<P STYLE="margin-right: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-right: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-right: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-right: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-right: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-right: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-right: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-right: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-right: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 90%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #706F61"><B>GENFIT</B></FONT>
<FONT STYLE="color: #706F61">| 885 Avenue Eug&egrave;ne Avin&eacute;e, 59120 Loos - FRANCE | +333 2016 4000 |</FONT> <FONT STYLE="color: #706F61">www.genfit.com</FONT></P>



</TD>
    <TD STYLE="text-align: right; width: 10%"><FONT STYLE="color: #706F61">3</FONT></TD></TR>
</TABLE>

<P STYLE="margin-right: 0; margin-bottom: 0"></P>

<P STYLE="margin-right: 0; margin-bottom: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-right: 0; margin-bottom: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>exh_992.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.2</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.85pt; text-align: center">June 19, 2020 FRENCH OFFICIAL
LEGAL ANNOUNCEMENT PUBLICATION &laquo;BALO&raquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1in; text-align: center"><B>Bulletin N&deg;74</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.9pt; text-align: center"><I>This document has been translated
in English for information only. In the event of any differences between the French text and the English text, the French language
version shall supersede</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7pt; text-align: center"><U>SHAREHOLDERS' AND UNITHOLDERS'
MEETINGS</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.15pt; text-align: center"><B>GENFIT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">French public limited
company (<I>Soci&eacute;t&eacute; Anonyme</I>)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">governed by a Board of Directors</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">with share capital of
9,714,654.25 euros</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Registered Office: 885 avenue Eug&egrave;ne Avin&eacute;e, 59120 Loos</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">424 341 907 R.C.S. Lille M&eacute;tropole</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.95pt; text-align: center"><U>Notice of second convocation</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.65pt 0pt 13pt; text-align: justify">Following the notice of meeting
serving as convocation published in the French Official Legal Announcement Publication &ldquo;BALO&rdquo; Bulletin No. 55 of May
6, 2020, Ladies and Gentlemen, the fellow shareholders of the company GENFIT S.A. (the &ldquo;<B>Company</B>&rdquo;) are informed
that the ordinary shareholders&rsquo; meeting convened at the Company&rsquo;s headquarters located Parc Eurasant&eacute;, 885 avenue
Eug&egrave;ne Avin&eacute;e in Loos (59120), on June 11, 2020 at 10 am, could not be deliberate due to the required quorum not
being reached.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.65pt 0pt 13pt; text-align: justify">Consequently, and in accordance
with applicable laws and regulations, the shareholders of the Company are notified of the holding of an ordinary shareholders&rsquo;
meeting convened on second convocation (the &quot;<B>Shareholders&rsquo; Meeting</B>&quot;), on Tuesday June 30, 2020 at 3 pm,
at the Company&rsquo;s headquarters located Parc Eurasant&eacute;, 885 avenue Eug&egrave;ne Avin&eacute;e in Loos (59120), in order
to deliberate on the same agenda. The text of the draft resolutions to be proposed to the shareholders&rsquo; meeting remains unchanged.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.6pt 0pt 13pt; text-align: justify">In view of the governmental
measures for the lockdown and prohibition of gatherings currently in force to fight against the spread of the epidemic of Coronavirus
(Covid-19), upon decision of the Board of Directors of the Company, the Shareholders&rsquo; Meeting will exceptionally be held
behind closed doors, that is to say without the presence of shareholders and other persons who are usually entitled to attend,
in accordance with the provisions of Article 4 of Ordinance No. 2020-321 of March 25, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.8pt 0pt 13pt; text-align: justify">The description of the procedures
which will allow shareholders to participate in the Shareholders&rsquo; Meeting notwithstanding these exceptional measures required
in order to comply with regulatory constraints and preserve the health of each person is set out in the second part of this conveying&rsquo;s
notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.85pt; text-align: center"><U>AGENDA</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7pt; text-align: center"><B>Ordinary Shareholders&rsquo;
Meeting</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 5.9pt"></TD><TD STYLE="width: 28.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: justify; padding-right: 5.7pt">Presentation of the Board of Directors&rsquo; management report on the Company's
activity and on the financial statements for the year ended on December 31, 2019, the Statutory Auditors' general report on the
accounts for the year ended on December 31, 2019;</TD></TR></TABLE>
<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; padding-top: 12pt; padding-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 5.9pt"></TD><TD STYLE="width: 28.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: justify; padding-right: 5.8pt">Presentation of the Group&rsquo;s management report by the Board of Directors
and reading of the Statutory Auditors' general report on the consolidated financial statements for the year ended on December 31,
2019;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 5.85pt"></TD><TD STYLE="width: 28.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left">Presentation of the Board of Directors&rsquo; corporate governance report;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 5.9pt"></TD><TD STYLE="width: 28.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: justify; padding-right: 5.65pt">Approval of the annual financial statements for the year ended on December
31, 2019 (<B>Resolution n&deg;1</B>);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 5.9pt"></TD><TD STYLE="width: 28.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: justify; padding-right: 6.15pt">Approval of the consolidated annual financial statements for the year ended
on December 31, 2019 (<B>Resolution n&deg;2</B>);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 5.85pt"></TD><TD STYLE="width: 28.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left">Allocation of the results for the year ended on December 31, 2019 (<B>Resolution n&deg;3</B>);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 5.9pt"></TD><TD STYLE="width: 28.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: justify; padding-right: 5.55pt">Reading and approval of the Statutory Auditors' special report on the regulated
agreements within the meaning of article L. 225-38 <I>et seq. </I>of the French <I>Code de commerce </I>previously authorised and
entered into and whose execution continued during the past financial year (<B>Resolution n&deg;4</B>);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 5.9pt"></TD><TD STYLE="width: 28.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: justify; padding-right: 6.1pt">Reading of the Board of Directors&rsquo; special report on the options to
subscribe or purchase Company&rsquo;s shares in accordance with article L. 225-184 of the French <I>Code de commerce</I>;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 5.9pt"></TD><TD STYLE="width: 28.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: justify; padding-right: 6.1pt">Reading of the Board of Directors&rsquo; special report on the granting of
free shares in accordance with article L. 225-197-4 of the French <I>Code de commerce</I>;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 5.9pt"></TD><TD STYLE="width: 28.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: justify; padding-right: 5.8pt">Reading of the table summarizing the delegations of authority and powers
granted by the shareholders&rsquo; meeting to the Board of Directors in respect of capital increases, in accordance with articles
L. 225-129-1 et seq. of the French <I>Code de commerce</I>;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 5.9pt"></TD><TD STYLE="width: 28.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: justify; padding-right: 5.7pt">Reading of the Board of Directors&rsquo; supplementary report on the use
of delegations of powers granted by the shareholders&rsquo; meeting, in accordance with article R. 225-116 of the French <I>Code
de commerce</I>;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 5.85pt"></TD><TD STYLE="width: 28.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left">Appointment of Mrs. Katherine KALIN as a member of the Board of Directors (<B>Resolution n&deg;5</B>);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 5.85pt"></TD><TD STYLE="width: 28.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left">Appointment of Mr. Eric BACLET as a member of the Board of Directors (<B>Resolution n&deg;6</B>);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 5.9pt"></TD><TD STYLE="width: 28.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: justify; padding-right: 6.15pt">Approval of the information relating to the components of overall compensation
paid during the 2019 financial year, or allocated for the same financial year, to all of the Company's corporate officers (<B>Resolution
n&deg;7</B>);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 5.9pt"></TD><TD STYLE="width: 28.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: justify; padding-right: 5.75pt">Approval of the components of overall compensation paid during the 2019
financial year, or allocated for the same financial year, to Mr. Jean-Fran&ccedil;ois MOUNEY, Chairman of the Board of Directors
of the Company (<B>Resolution n&deg;8</B>);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 5.9pt"></TD><TD STYLE="width: 28.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: justify; padding-right: 6.05pt">Approval of the components of overall compensation paid during the 2019
financial year, or allocated for the same financial year, to Mr. Pascal PRIGENT, Chief Executive Officer of the Company (<B>Resolution
n&deg;9</B>);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 5.9pt"></TD><TD STYLE="width: 28.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: justify; padding-right: 5.9pt">Approval of the compensation policy for financial year 2020 applicable to
all of the Company's corporate officers (<B>Resolution n&deg;10</B>);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 5.9pt"></TD><TD STYLE="width: 28.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: justify; padding-right: 5.7pt">Approval of the compensation policy for financial year 2020 applicable to
Mr. Jean-Fran&ccedil;ois MOUNEY, Chairman of the Board of Directors of the Company (<B>Resolution n&deg;11</B>);</TD></TR></TABLE>
<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; padding-top: 12pt; padding-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 5.9pt"></TD><TD STYLE="width: 28.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; padding-right: 5.8pt">Approval of the compensation policy for financial year 2020 applicable to Mr.
Pascal PRIGENT, Chief Executive Officer of the Company (<B>Resolution n&deg;12</B>);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 5.9pt"></TD><TD STYLE="width: 28.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; padding-right: 5.85pt">Approval of the compensation policy for financial year 2020 applicable to the
Directors of the Company (<B>Resolution n&deg;13</B>); and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 5.85pt"></TD><TD STYLE="width: 28.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left">Powers to carry out formalities (<B>Resolution n&deg;14</B>).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.35pt; text-align: center">*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 12.95pt"></TD><TD STYLE="width: 9.05pt">I.</TD><TD STYLE="text-align: left">Preliminary formalities to complete in order to participate to the Shareholders&rsquo; Meeting</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.45pt 0pt 13pt; text-align: justify">Within the framework of Ordinance
no. 2020-321 of March 25, 2020 (the &ldquo;<B>Covid-19 Ordinance</B>&rdquo;) adapting the rules for meeting and deliberation of
meetings and governing bodies of legal persons and entities without legal personality of private law due to the Covid-19 epidemic,
and with the constant concern of ensuring, as far as possible, the security and protection of all stakeholders (including those
of investors) at the Shareholders&rsquo; Meeting, this meeting will be held without the physical attendance of the shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13pt">Under these conditions and in accordance with the Covid-19
Ordinance, in order to exercise your rights, you must:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 30.95pt"></TD><TD STYLE="width: 18.05pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: left">favour the use of the Internet for the completion of participation formalities,</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 31pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify; padding-right: 5.55pt">express your choices before the meeting with respect to the resolutions
that are proposed to you, namely by:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 66.95pt"></TD><TD STYLE="width: 18.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD STYLE="text-align: left">voting by post,</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 67pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD STYLE="text-align: justify; padding-right: 5.5pt">appointing a proxy who will vote before the Shareholders&rsquo; Meeting (the
latter then having the option of communicating his voting instructions to the following address: paris.bp2s.france.cts.mandats@bnpparibas.com),</TD></TR>                                                                                                                                                                                                                                                                                                                                                                                                                                                                           <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify; padding-right: 5.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>o</TD><TD STYLE="text-align: justify; padding-right: 5.5pt">granting a power of attorney to the President of
the Shareholders&rsquo; Meeting, </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13pt"><B><U>only options now available due to the circumstances and imperatives above-mentioned.</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13pt">You may also ask questions in writing. These questions must:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 70.6pt 0pt 13pt; text-align: justify; text-indent: 53.95pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 31pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify; padding-right: 5.45pt">be sent by registered letter with acknowledgment of receipt to the following
address: GENFIT, Service Financier, Parc Eurasant&eacute;, 885 avenue Eug&egrave;ne Avin&eacute;e, 59120 Loos or by electronic
communication to the following address: investors@genfit.com at the latest on the fourth business day preceding the date of the
Shareholders&rsquo; Meeting;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 30.95pt"></TD><TD STYLE="width: 18.05pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: left">be accompanied by a shareholding certificate of your GENFIT&rsquo;s shares to be taken into account.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 14.15pt 0pt 13pt">Please be reminded that the proxy and postal
voting forms received by the company for the June 11, 2020 meeting remain valid for this Shareholders&rsquo; Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 14.15pt 0pt 13pt">Finally, shareholders are invited to regularly
consult the section dedicated to the 2020 Shareholders&rsquo; Meeting on the Company's website: www.genfit.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 12.95pt"></TD><TD STYLE="width: 13.15pt">II.</TD><TD STYLE="text-align: left">Participation&rsquo;s terms to the Shareholders&rsquo; Meeting</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; padding-top: 12pt; padding-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13pt; text-align: justify">The Shareholders&rsquo; Meeting
is composed of all shareholders regardless of the number of shares they hold.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.5pt 0pt 13pt; text-align: justify">Each shareholder may be represented
at the Shareholders&rsquo; Meeting by another shareholder, by their spouse or by the partner with whom they have concluded a civil
solidarity pact. They may also be represented by any other natural or legal person of their choice (article L. 225-106 of the French
<I>Code de commerce</I>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13pt; text-align: justify">The proxy thus designated will
vote remotely under the conditions set out in III. below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.45pt 0pt 13pt; text-align: justify">In accordance with article
R. 225-85 of the French <I>Code de commerce</I>, the right to participate in the Shareholders&rsquo; Meeting is justified by registering
the securities in the name of the shareholder or the intermediary registered on their behalf (in application of the seventh paragraph
of article L. 228-1 of the French <I>Code de commerce</I>), on the second day preceding the Shareholders&rsquo; Meeting at midnight,
Paris time, either in the registered securities accounts kept by the Company (or its agent ), or in the bearer (<I>au porteur</I>)
securities accounts kept by the authorized intermediary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.4pt 0pt 13pt; text-align: justify">The registration of the securities
in the bearer (<I>au porteur</I>) securities accounts kept by the financial intermediaries is evidenced by a participation certificate
issued by the latter (if necessary by electronic means) under the conditions provided for in article R. 225-85 of the French <I>Code
de commerce </I>(with reference to article R. 225-61 of the same <I>Code</I>), in the appendix:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 30.95pt"></TD><TD STYLE="width: 18.05pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: left">the remote voting form;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 30.95pt"></TD><TD STYLE="width: 18.05pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: left">the voting proxy.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 12.95pt"></TD><TD STYLE="width: 17.2pt">III.</TD><TD STYLE="text-align: left">Vote by post or proxy</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 12.95pt"></TD><TD STYLE="width: 12.75pt">A.</TD><TD STYLE="text-align: justify"><U>Postal voting</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13pt">Shareholders wishing to vote by post or be represented
by giving a proxy to the Chairman of the Shareholders&rsquo; Meeting or to a proxy may:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 31pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify; padding-right: 5.45pt"><I>For registered shareholders</I>: return the postal or proxy voting form,
which will be sent to them with the invitation, to the following address: BNP Paribas Securities Services - CTO Service Assembl&eacute;es
- Grands Moulins de Pantin - 9, rue du D&eacute;barcad&egrave;re - 93761 Pantin Cedex.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 31pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify; padding-right: 5.4pt"><I>For bearer (</I>au porteur<I>) shareholders</I>: request this postal or
proxy voting form from the intermediary who manages their securities as of the date of the Shareholders&rsquo; Meeting. Once filled
by the shareholder, this form will be returned to the account-keeping establishment, which will include a participation certificate
and send it to BNP Paribas Securities Services - CTO Service Assembl&eacute;es - Grands Moulins de Pantin - 9 , rue du D&eacute;barcad&egrave;re
- 93761 Pantin Cedex. To be taken into account, the postal voting forms must be received by the Company or the Shareholders&rsquo;
Meetings Service of BNP Paribas Securities Services, at the latest on 27 June 2020.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13pt">The appointments or revocations of agents expressed
on paper must be received no later than the fourth day preceding the date of the Shareholders&rsquo; Meeting, <I>i.e. </I>June
26, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 12.95pt"></TD><TD STYLE="width: 12.15pt">B.</TD><TD STYLE="text-align: left"><U>Electronic voting</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.35pt 0pt 13pt; text-align: justify">Shareholders also have the
possibility of transmitting their voting instructions, of granting a power of attorney to the President of the Shareholders&rsquo;
Meeting before the Shareholders&rsquo; Meeting, and of appointing or removing a proxy by Internet before the Shareholders&rsquo;
Meeting on the Votaccess website, in accordance with the conditions described below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13pt; text-align: justify"><U>For registered shareholders
(<I>actionnaires au nominatif</I>):</U></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; padding-top: 12pt; padding-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13pt; text-align: justify"><U></U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13pt">Holders of pure or administered registered shares who
wish to vote by Internet will access the Votaccess&rsquo; website via the Planetshares site, the address of which is as follows:
https://planetshares.bnpparibas.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13pt">Holders of pure registered shares must connect to the
Planetshares site with their usual access codes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.05pt 0pt 13pt">Holders of administered registered shares will
have to connect to the Planetshares site using their identification number, which is found at the top right of their paper voting
form. In the event that the shareholder is no longer in possession of their username and / or password, they may contact the number
made available to them, being either 01 57 43 02 30 from France or +33 1 57 43 02 30 from abroad, or use the contact form on the
Planetshares website: https://planetshares.bnpparibas.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.05pt 0pt 13pt">After logging in, the registered shareholder must
follow the instructions given on the screen in order to access the Votaccess&rsquo; website and vote, or appoint or dismiss a proxy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.05pt 0pt 13pt">The appointments or revocations of proxies must
be received no later than the fourth day preceding the date of the Shareholders&rsquo; Meeting, <I>i.e. </I>June 26, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13pt"><U>For bearer shareholders (<I>actionnaires au porteur</I>):</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.5pt 0pt 13pt; text-align: justify">It is up to the bearer shareholder
to inquire in order to know whether his account-keeping establishment is connected or not to the Votaccess&rsquo; website and,
if necessary, if this access is subject to specific conditions of use.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.35pt 0pt 13pt; text-align: justify">If the shareholder's account-keeping
establishment is connected to the Votaccess&rsquo; website, the shareholder must identify himself on the Internet portal of his
account-keeping establishment with his usual access codes. He must then click on the icon which appears on the line corresponding
to his actions and follow the indications given on the screen in order to access the Votaccess&rsquo; website and vote, grant a
power of attorney to the President of the Shareholders&rsquo; Meeting or appoint or dismiss a proxy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.3pt 0pt 13pt; text-align: justify">If the shareholder's account-keeping
establishment is not connected to the Votaccess&rsquo; website, it is specified that the notification of the appointment and the
revocation of a proxy may however be made electronically in accordance with the provisions of the article R. 225-79 of the French
<I>Code de commerce</I>, in the following ways:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 31.7pt"></TD><TD STYLE="width: 35.3pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify; padding-right: 5.6pt">the shareholder must send an email to paris.bp2s.france.cts.mandats@bnpparibas.com.
This email must contain the following information: name of the Company concerned, date of the Shareholders&rsquo; Meeting, last
name, first name, address, bank references of the principal as well as the name, first name and if possible the address of the
agent; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 31.7pt"></TD><TD STYLE="width: 35.3pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify; padding-right: 5.45pt">the shareholder must obligatorily ask their financial intermediary who manages
their securities account to send a written confirmation to the Shareholders&rsquo; Meetings department of BNP Paribas Securities
Services - CTO Service Assembl&eacute;es - Grands Moulins de Pantin - 9, rue du D&eacute;barcad&egrave;re - 93761 Pantin Cedex.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.6pt 0pt 13pt; text-align: justify">Only notifications of designation
or revocation of mandates may be sent to the aforementioned email address, any other request or notification relating to another
object that cannot be taken into account and/or processed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.4pt 0pt 13pt; text-align: justify">In order for appointments
or revocations of proxies expressed by electronic means to be validly taken into account, confirmations must be received no later
than the fourth day preceding the date of the meeting, <I>i.e. </I>June 26, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13pt; text-align: justify">The Votaccess&rsquo; website will
be reopened from June 19, 2020.</P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; padding-top: 12pt; padding-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13pt; text-align: justify">The possibility of voting
online before the Shareholders&rsquo; Meeting will end the day before the meeting, <I>i.e. </I>June 29, 2020 at 3:00 p.m.
Paris time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.55pt 0pt 13pt; text-align: justify">However, in order to avoid
any possible congestion on the Votaccess&rsquo; website, shareholders are advised not to wait until the day before the Shareholders&rsquo;
Meeting to vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.6pt 0pt 13pt; text-align: justify">Both registered shareholders
and bearer shareholders may appoint a proxy under the conditions indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.6pt 0pt 13pt; text-align: justify">In accordance with decree
2020-418 of April 10, 2020, the proxy thus appointed shall send, no later than the 4th day preceding the date of the Shareholders&rsquo;
Meeting, an email containing the voting instructions in the form of the single form by electronic message to the address: paris.bp2s.france.cts.mandats@bnpparibas.com.
This email must contain the following information: name of the Company concerned, date of the Shareholders&rsquo; Meeting, last
name, first name, address, principal's bank details as well as the name, first name and, if possible, the address of the proxy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.6pt 0pt 13pt; text-align: justify">In accordance with decree
2020-418 of April 10, 2020, a shareholder who has already cast his vote at a distance, sent a proxy or requested his admission
card or a certificate of participation can choose another mode of participation in the Shareholders&rsquo; Meeting provided that
its instruction in this sense reaches the company within a timeframe compatible with the taking into account of the new instructions.
The previous instructions received are then revoked.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13pt; text-align: justify">Written questions</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.55pt 0pt 13pt; text-align: justify">In accordance with article
R. 225-84 of French <I>Code de commerce</I>, each shareholder has the possibility to send to the Board of Directors, which should
answer during the meeting, the written questions of his choice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.55pt 0pt 13pt; text-align: justify">The questions shall be sent
by registered letter with acknowledgement of receipt at the following address GENFIT, Service Financier, Parc Eurasant&eacute;,
885 avenue Eug&egrave;ne Avin&eacute;e, 59120 Loos or by email to the following address: investors@genfit.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.55pt 0pt 13pt; text-align: justify">This mailing shall be realised
at the latest the fourth business day preceding the date of the Shareholders&rsquo; Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13pt; text-align: justify">Rights to shareholder information</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.4pt 0pt 13pt; text-align: justify">All the documents and information
set forth in article R. 225-73-1 of the French <I>Code de commerce </I>shall be consulted on the issuer&rsquo;s website: www.genfit.fr
as from the 21<SUP>st</SUP> day before the shareholders&rsquo; meeting initially convened for June 11, 2020, being May 20, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.05pt; text-align: center">*****</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13pt; text-align: justify">The Board of Directors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13pt; text-align: justify">&nbsp;</P>



<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #" P\# 2(  A$! Q$!_\0
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M':=AAIWW#_=' _K7GY-!RQ::Z79Z.:34<,T^MC:N[RWT^SEN[J58H(E+N[=
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M#I__ (,F_P#C5.^W^*?^@#I__@S;_P"-4<C_ *8>T79_<;I%,9:Q/MWBG_H
MZ?\ ^#)O_C5--_XH_P"@#I__ (,F_P#C5'(_Z8>T79_<;!&#3Q6";[Q1_P!
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M..34Z#BJT3;CFK24@)!3L4@IU( I*6FF@89HS244Q :2@FF[J '4N:9NI=U
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MKSV]Z]7U/P]I6K6$=C>6:/;Q?ZM%)39QCC&,5DV/P[\-V5RLZ6)D=3E1-(6
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MI1Y:,,A@.E $1ADC(,BD#U'-.N'SA?;H:GBF=T#/P!Z5)+<PW2!'1 XZ$=:
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M>J\)._KWHHH0'0Z0[D[2S%?3/%9FJHJW(VJ!\W8444+<"74N+&W X&*S8?\
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M0=:**8AZU*M%%(!PIU%% Q:***0!1110,*#110(2BBBF M(:** &FHVZ444
M0/3%HHJ)%1)5J&__ ./&3\/YBBBHELS2/Q(Y^7O38/\ 6445S+<ZI;&U;?=%
M6QTHHKJ6QQO<0]*KR@444F-&;.HW'@5 JC=T'Y445GU-31MQTK3C^[115P,I
$[G__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
